Recent news on Reteplase

FDA Approves Enoxaparin for STEMI  -  25 May 2007
Medscape (subscription)25 study that involved 25506 patients with STEMI who were scheduled to undergo fibrinolysis with streptokinase, tenecteplase, alteplase, or reteplase.

Metro Briefs  -  Apr 18, 2007
Washington Times,Larry Bruni, 55, claimed he injected a blood thinner called Reteplase into one patient more than 100 times, according to court records.

New Guidelines for Treatment of Acute Ischemic Stroke  -  Apr 19, 2007
Medscape (subscription)Treatment with streptokinase is not recommended, and reteplase, urokinase, and other thrombolytic agents should not be used outside of the setting of a

Diosynth Extends Commercial Supply Ageement with PDL BioPharma  -  Feb 7, 2007
Genetic Engineering News (press release),Diosynth Biotechnology signed an extension of its exclusive agreement with PDL BioPharma for the commercial manufacture of Retavase® (reteplase),

Heart attack drug back on track after manufacturing issues  -  Feb 14, 2007
OutSourcing-Pharma.com,...supply of PDL’s heart attack treatment Retavase (reteplase), a move that signals the end of manufacturing issues PDL experienced with the drug.

Diosynth Biotechnology Announces Extension of Commercial Supply ...  -  Feb 7, 2007
dBusinessNews Triangle (press release),Inc. for the commercial manufacture of Retavase® (reteplase), a fibrinolytic agent that has been marketed in North America since October 1996.

Management of Venous Thromboembolism: A Clinical Practice ...  -  Feb 5, 2007
Annals of Internal MedicineReteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol. 2000;11:849-54. [Abstract/Free Full Text]

TIMI, TIBI, TICI: I Came, I Saw, I Got Confused  -  Feb 12, 2007
AJNR (subscription),Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. AJNR Am J Neuroradiol 2006;27:769–73 [Abstract/Free

ACEP: Angioplasty Delayed is Fibrinolytic Therapy Denied  Oct 16, 2006
...coronary intervention was the time delay. The study was funded by PDL BioPharma, maker of the fibrinolytic agent Retavase (reteplase). -MedPage Today, Heart attack survivor says research is key  Sep 21, 2006
His heart had actually stopped and they brought him back with the drug rPA (the powerful blood thinner reteplase) which is $3,000 a shot and he had to have two ... -Penticton Herald

Insulin fights heart attack  Aug 8, 2006
...administered two units of insulin an hour intravenously for two days. The insulin will be given alongside the clot-busting drug Reteplase. -Times of India



ROSIE Trial Shows Abciximab May Be Most Effective Combined With ...  Feb 21, 2006
KISSIMMEE, FL -- February 21, 2006 -- Abciximab (ReoPro) may be more effective in combination with reteplase (Retavase) for patients with acute ischemic stroke ... - DG News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional